LCHADD Retinopathy

October 05, 2022 01:07:05
LCHADD Retinopathy
MitoAction Expert Series
LCHADD Retinopathy

Oct 05 2022 | 01:07:05

/

Show Notes

The underlying cause of LCHADD retinopathy is not fully understood. This presentation will look at the research that identifies the cell in the eye that is initially affected and characteristics associated with vision loss. Join Dr. Gillingham as she discusses early data on the natural history study and some new pre-clinical models to test novel treatments for LCHADD retinopathy.

Other Episodes

Episode

August 18, 2022 01:02:07
Episode Cover

Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update

There was much discussion about current research in FAODs at our recent International Metabolic conference last month. Reneo Pharmaceuticals recently released positive results from...

Listen

Episode

June 22, 2022 01:05:25
Episode Cover

Coping with Mitochondrial Disease - 10/5/2009

MitoAction welcomes psychologist Carole Slipowitz PhD and Tufts Metabolism clinic nurse coordinator Maggie Orr RN M.Ed to discuss the challenges of dealing with a...

Listen

Episode

April 12, 2022 01:38:22
Episode Cover

What you Should Know About Disability Rights - Valerie Powers Smith - 2/1/2008

Join MitoAction in an informative and exciting discussion with disability advocate and attorney Valerie Powers Smith as she brings to light issues regarding health...

Listen